Minister for Science champions partnerships with private clinical sector in UK
Lord Patrick Vallance has emphasised plans for a close collaboration between the government and private sector, in line with the …
Lord Patrick Vallance has emphasised plans for a close collaboration between the government and private sector, in line with the …
While Parkinson’s disease (PD) has a large and highly generalised therapeutic market, key opinion leaders (KOLs) interviewed by GlobalData have …
Vidac Pharma has secured €600,000 ($645,651) in additional funding to support the clinical development of its two lead cancer candidates. The …
Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with relapsed or …
As data management applications become more commonplace across the clinical sphere, and teams search for new ways to use technology …
Alcon decided to take a platform-based approach to support its clinical transformation efforts when parent company Novartis decided to spin …
Bavarian Nordic’s mpox vaccine, Jynneos (MVA-BN), is set to be trialled in pregnant and breastfeeding women and infants. The Phase III …
Castle Biosciences has released data from a multi-centre DECIDE study showing the impact of integrating its DecisionDx-Melanoma test results into …
Senhwa Biosciences has enrolled the first subject for a Phase I/II trial at Penn State Health Children's Hospital to evaluate …
Ionis Pharmaceuticals has announced the design for a pivotal Phase III trial of ION582, an investigational treatment for AS, following …
Former health minister Lord James O’Shaughnessy said the UK is “building from a position of strength” as he assessed commercial …
Penumbra has posted positive data for its computer-assisted vacuum thrombectomy (CAVT) technology aimed at treating patients with intermediate-risk pulmonary embolism …
Following Donald Trump’s re-election as the 47th President of the United States, the global healthcare community is beginning to examine …
Zymeworks has dosed the first patient in its Phase I clinical trial of ZW191, an investigational therapy, aimed at treating …
Having raised the full-year sales guidance for Caplyta (lumateperone) a week ago, Intra-Cellular Therapeutics has reported positive topline data from …